Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)

Byung-Wan Lee

doi:10.4093/dmj.2013.37.3.212

Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)

Diabetes & Metabolism Journal ◽

10.4093/dmj.2013.37.3.212 ◽

2013 ◽

Vol 37 (3) ◽

pp. 212

Author(s):

Byung-Wan Lee

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Antidiabetic Therapy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study

Diabetes & Metabolism Journal ◽

10.4093/dmj.2013.37.2.117 ◽

2013 ◽

Vol 37 (2) ◽

pp. 117 ◽

Cited By ~ 5

Author(s):

Kee-Ho Song ◽

Jung Min Kim ◽

Jung-Hyun Noh ◽

Yongsoo Park ◽

Hyun-Shik Son ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Antidiabetic Therapy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

Response: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)

Diabetes & Metabolism Journal ◽

10.4093/dmj.2013.37.3.214 ◽

2013 ◽

Vol 37 (3) ◽

pp. 214

Author(s):

Kee-Ho Song ◽

Jung Min Kim ◽

Jung-Hyun Noh ◽

Yongsoo Park ◽

Hyun-Shik Son ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Antidiabetic Therapy ◽

Response Efficacy ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti

Diabetes Obesity and Metabolism ◽

10.1111/dom.13454 ◽

2018 ◽

Vol 20 (12) ◽

pp. 2740-2747

Author(s):

Lixin Guo ◽

Li Chen ◽

Baocheng Chang ◽

Liyong Yang ◽

Yu Liu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Diabetes Patients

Download Full-text

Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: An 18-week, randomized, open-label study

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.09.001 ◽

2005 ◽

Vol 27 (9) ◽

pp. 1432-1443 ◽

Cited By ~ 15

Author(s):

Itamar Raz ◽

Stephen Stranks ◽

Robert Filipczak ◽

Pankaj Joshi ◽

Benedikte Lertoft ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.02.023 ◽

2019 ◽

Vol 150 ◽

pp. 158-166 ◽

Cited By ~ 1

Author(s):

Wenying Yang ◽

Canan Ersoy ◽

Guixia Wang ◽

Shandong Ye ◽

Jun Liu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2007.00743.x ◽

2007 ◽

Vol 9 (5) ◽

pp. 724-732 ◽

Cited By ~ 21

Author(s):

W. M. W. Bebakar ◽

C. C. Chow ◽

K. A. Kadir ◽

S. Suwanwalaikorn ◽

J. A. Vaz ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Antidiabetic Treatment ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT

Current Medical Research and Opinion ◽

10.1185/03007990903354674 ◽

2009 ◽

Vol 25 (12) ◽

pp. 2887-2894 ◽

Cited By ~ 56

Author(s):

Krzysztof Strojek ◽

Wan M.W. Bebakar ◽

Duma T. Khutsoane ◽

Milica Pesic ◽

Alena Šmahelová ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Aspart ◽

Oral Drugs ◽

Open Label ◽

Once Daily ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus

Clinical Therapeutics ◽

10.1016/s0149-2918(04)90055-0 ◽

2004 ◽

Vol 26 (4) ◽

pp. 531-540 ◽

Cited By ~ 67

Author(s):

L NISKANEN

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Lispro ◽

Insulin Aspart ◽

Open Label ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

P-27 Treatment with biphasic insulin aspart 30 improves glycaemic control in patients with Type 2 diabetes inadequately controlled with oral antidiabetic drugs: results from China cohort in the PRESENT study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(08)70801-5 ◽

2008 ◽

Vol 79 ◽

pp. S64-S65

Author(s):

Yan Gao

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Aspart ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 diabe

Journal of Diabetes Investigation ◽

10.1111/j.2040-1124.2010.00015.x ◽

2010 ◽

Vol 1 (3) ◽

pp. 103-110 ◽

Cited By ~ 4

Author(s):

Takashi Kadowaki ◽

Tomoyuki Nishida ◽

Kohei Kaku

Keyword(s):

Insulin Aspart ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Trial ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Parallel Group

Download Full-text